News and Events

Five years later, an immunotherapy trial for prostate cancer sustains hope

In 2018, we interviewed Tom, a retired surgeon battling prostate cancer who, in 2016, enrolled on an immunotherapy clinical trial led by James Gulley, M.D., Ph.D., Co-Director of the Center for Immuno-Oncology. Now, five years since he first started on the trial, his PSA levels have remained undetectable and his scans continue to come back clean.

Steven A. Rosenberg selected as Icon in Surgery by ACS

Steve Rosenberg, M.D., Ph.D., Chief of the Surgery Branch, has been selected as an Icon in Surgery by the American College of Surgeons. He is being highlighted for being a pioneer in the development of oncologic immunotherapy and gene therapy for patients with advanced cancer. Dr. Rosenberg will be giving a video-based presentation at the 2022 ACS Clinical Congress to discuss his work.

NCI RNA Biology Initiative Retreat - October 25, 2022

RNA biology has emerged as one of the most influential areas in modern biology and biomedicine. NCI is home to a wide spectrum of work in RNA biology ranging from elucidating RNA biogenesis and structure, identifying functions for various classes of RNAs, establishing the role of RNA in disease, and exploring RNA-based and RNA-targeted therapies.

The goal of this retreat, hosted by the NCI RNA Biology Initiative, is to enhance interactions amongst PIs, fellows and staff working on RNA and to foster new collaborations and synergies amongst NIH laboratories interested in RNA biology. The retreat will feature our keynote speaker, Julie M. Claycomb, Ph.D., University of Toronto and several talks selected from submitted abstracts. Fellows, staff scientists and trainees (including Leidos contractors) are encouraged to submit an abstract for consideration. We also hope to catalyze interactions between basic and clinician researchers at this retreat.

Event banner for The Biology & Biophysics of the Nucleus Symposium

Biology & Biophysics of the Nucleus Symposium - October 20-21, 2022

The mission of the Center of Excellence in Chromosome Biology (CECB) is to achieve a comprehensive understanding of the mechanisms involved in chromosome function, how aberrations in chromosomes and chromatin lead to disease and how these defects can be corrected.

Towards achieving the mission, the Biology & Biophysics of the Nucleus Symposium brings together scientists in the fields of chromatin and chromosome biology, with the focus on stem cells, cell development, aging and cancer.

We hope this symposium offers you an opportunity to learn more about the current status of chromosome structure and function in development and disease, to share your research and to discuss the use and implications of these advances for clinical applications.

Organized by: Shalini Oberdoerffer, Ph.D., Gordon Hager, Ph.D., and Dave Levens, M.D., Ph.D.

Clinical trial researching therapy for bile duct cancer

A clinical trial led by Jonathan Hernandez, M.D., Investigator in the Surgical Oncology Program, is researching a combination of immunotherapy and chemotherapy for liver-only cholangiocarcinoma.

Celebrating Hispanic Heritage Month: A Conversation with Cecilia Monge, M.D., M.P.H., F.A.C.P.

Cecilia Monge, M.D., M.P.H., F.A.C.P., is an Assistant Research Physician in the Thoracic and GI Malignancies Branch. She is from Costa Rica where she completed medical school and worked for ten years. For this Hispanic Heritage Month Q&A, she tells us about her interests in health disparities research, her experience working in a developing country and what makes a good mentor.

Aligned Blog: Celebrating Hispanic Heritage!

Happy Hispanic Heritage Month! For this edition of Aligned, I thought I would celebrate some of my Latino/a/x friends and colleagues here at the Center for Cancer Research. I asked each of them to “Tell me why your Hispanic Heritage is important to you (and something you love about it).” I hope they inspire you to learn more about the many ways in which we have all benefitted from their Hispanic Heritage.

Kylynda Bauer, Ph.D., a postdoctoral fellow in the laboratory of Tim Greten, M.D., Deputy Chief and Senior Investigator in the Thoracic and GI Malignancies Branch.

Celebrating Hispanic Heritage Month: A Conversation with Kylynda Bauer, Ph.D.

Kylynda Bauer, Ph.D., is an iCURE scholar in the Thoracic and GI Malignancies Branch. In this Hispanic Heritage Month Q&A, she speaks to us about the influences of her diverse cultural background, the importance of reaching out to others and what she enjoys about the iCURE program.

The middle portion of the gastrointestinal tract is a common location for cancerous neuroendocrine tumors to form.

Clinical trial evaluates drug combination for inoperable neuroendocrine tumors

Neuroendocrine tumors occur in cells of the endocrine and nervous systems. A combined phase I/II clinical trial at the NIH Clinical Center evaluates the effectiveness of a combination of two agents that may work in complementary ways to target inoperable or metastatic neuroendocrine tumors.

image of female physician using a stethoscope on a young female patient

Clinical trial researching T-cell therapy for sarcoma

John W. Glod, M.D., Ph.D., Associate Research Physician in the Pediatric Oncology Branch, is leading NCI’s participation in a clinical trial researching T-cell therapy for sarcomas.

Breadcrumb